Table of Content




2. Market Background and Classifications
2.1 Introduction, Background, and Classifications
2.2 Supply Chain
2.3 Industry Drivers and Challenges


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1 Macroeconomic Trends and Forecast
3.2 Global Regenerative Medicine Market Trends and Forecast
3.3 Global Regenerative Medicine Market by Material
3.3.1 Synthetic
3.3.1.1 Scaffold
3.3.1.2 Artificial Vascular Graft Materials
3.3.1.3 Hydrogel Materials
3.3.2 Biologically Derived Materials
3.3.2.1 Collagen
3.3.2.2 Xenogeneic Materials
3.3.3 Genetically Engineered Materials
3.3.3.1 Deoxyribonucleic Acid Transfection Vectors
3.3.3.2 Genetically Manipulated Cells
3.3.3.3 Three-dimensional Polymer Technology
3.3.3.4 Transgenics
3.3.3.5 Fibroblasts
3.3.3.6 Neural Stem Cells
3.3.3.7 Gene-activated Matrices
3.3.4 Pharmaceuticals
3.3.4.1 Small Molecules
3.3.4.2 Biologics
3.4 Global Regenerative Medicine Market by Product
3.4.1 Cell-Based Immunotherapy & Cell Therapy Products
3.4.2 Tissue-Engineered Products
3.4.3 Small Molecules And Biologics
3.4.4 Gene Therapy Products
3.5 Global Regenerative Medicine Market by Application
3.5.1 Musculoskeletal Disorders
3.5.2 Wound Care
3.5.3 Oncology
3.5.4 Ocular Disorders
3.5.5 Diabetes
3.5.6 Other Applications
3.6 Global Regenerative Medicine Market by Distribution Channel
3.6.1 Hospitals
3.6.2 Clinic
3.6.3 Others


4. Market Trends and Forecast Analysis by Region
4.1 Global Regenerative Medicine Market by Region
4.2 North American Regenerative Medicine Market
4.2.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
4.2.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
4.2.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
4.2.4 Market by Distribution Channel: Hospitals, Clinics, and Others
4.2.5 The United States Regenerative Medicine Market
4.2.6 The Canadian Regenerative Medicine Market
4.2.7 The Mexican Regenerative Medicine Market
4.3 European Regenerative Medicine Market
4.3.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
4.3.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
4.3.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
4.3.4 Market by Distribution Channel: Hospitals, Clinics, and Others
4.3.5 The Regenerative Medicine Market of the United Kingdom
4.3.6 The German Regenerative Medicine Market
4.3.7 The French Regenerative Medicine Market
4.4 APAC Regenerative Medicine Market
4.4.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
4.4.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
4.4.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
4.4.4 Market by Distribution Channel: Hospitals, Clinics, and Others
4.4.5 The Chinese Regenerative Medicine Market
4.4.6 The Indian Regenerative Medicine Market
4.4.7 The Japanese Regenerative Medicine Market
4.5 ROW Regenerative Medicine Market
4.5.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
4.5.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
4.5.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
4.5.4 Market by Distribution Channel: Hospitals, Clinics, and Others
4.5.5 Brazilian Regenerative Medicine Market


5. Competitor Analysis
5.1 Market Share Analysis
5.2 Product Portfolio Analysis
5.3 Operational Integration
5.4 Geographical Reach
5.5 Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1 Growth Opportunity Analysis
6.1.1 Growth Opportunities for the Global Regenerative Medicine Market by Material
6.1.2 Growth Opportunities for the Global Regenerative Medicine Market by Product
6.1.3 Growth Opportunities for the Global Regenerative Medicine Market by Application
6.1.4 Growth Opportunities for the Global Regenerative Medicine Market by Distribution Channel
6.1.5 Growth Opportunities for the Global Regenerative Medicine Market by Region
6.2 Emerging Trends in the Global Regenerative Medicine Market
6.3 Strategic Analysis
6.3.1 New Product Development
6.3.2 Capacity Expansion of the Global Regenerative Medicine Market
6.3.3 Mergers, Acquisitions, and Joint Ventures in the Global Regenerative Medicine Market


7. Company Profiles of Leading Players
7.1 Kite Pharma
7.2 Novartis
7.3 Vericel Corporation
7.4 Integra LifeSciences
7.5 Wright Medical
7.6 MiMedx
7.7 Osiris Therapeutics
7.8 Stryker Corporation
7.9 Spark Therapeutics
7.10 Zimmer Biomet Holdings, Inc.